Hello and Welcome to Patientsville.com, Your Source for all ESTRACE information. We are dedicated to provide You with ESTRACE safety information. Learn about ESTRACE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ESTRACE Safety Reports
Total ESTRACE reports: 66.ESTRACE FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 3.
Take ESTRACE Side Effects Survey or Share Your ESTRACE Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Dec 28, 2006. Female patient, 74 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, breast cancer female. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROMETRIUM. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2007. Female patient, 78 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, ESTRADIOL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Jan 12, 2007. Female patient, 59 years of age, was diagnosed with menopausal symptoms, osteoporosis and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PROMETRIUM, MEDROXYPROGESTERONE, ESTRADIOL. Patient died on 06/06/2006.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2007. Female patient, 67 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, CLIMARA, MEDROXYPROGESTERONE, CONJUGATED ESTROGENS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Mar 09, 2007. Female patient, 54 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, PREMARIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Female patient, 54 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer stage ii. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, PREMARIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Sept 05, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PREMPRO, ESTRATEST, CENESTIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Female patient, 57 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on May 02, 2007. Female patient, 76 years of age, weighting 114.0 lb, was diagnosed with vulvovaginal dryness and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: burning sensation, complication of device insertion, parathyroidectomy, spinal laminectomy, unevaluable event, urinary tract infection, vulvovaginal discomfort. ESTRACE dosage: unknown. During the same period patient was treated with CALCIUM, VITAMIN E, ACTONEL, SOTALOL, DIOVAN, LOVASTATIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Female patient, 67 years of age, weighting 164.9 lb, was diagnosed with vulvovaginal dryness and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: colon cancer, small intestine carcinoma metastatic, small intestine carcinoma stage iv. ESTRACE dosage: unknown. During the same period patient was treated with SYNTHROID, ALLEGRA, INDERAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on June 11, 2007. Female patient, 50 years of age, weighting 240.3 lb, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, 51 years of age, weighting 130.1 lb, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, PREMARIN, ESTRATEST, CLIMARA, PROGESTERONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on June 28, 2006. Female patient, 67 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, ESTRADIOL, ESTRATEST. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2006. Female patient, 74 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, ESTRATEST, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 06, 2006. Female patient, 64 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2006. Female patient, 64 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, oestrogen receptor assay positive, progesterone receptor assay positive. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 12, 2005. Female patient, 58 years of age, was diagnosed with alopecia and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: headache. ESTRACE dosage: unknown. During the same period patient was treated with ROGAINE. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 15, 2005. Female patient, 58 years of age, weighting 160.9 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: abdominal pain. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Sept 15, 2005. Female patient, 46 years of age, weighting 160.9 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: dyspareunia, vaginal pain. ESTRACE dosage: unknown. During the same period patient was treated with LIPITOR, TOPAMAX, CYMBALTA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2006. Female patient, 59 years of age, weighting 216.1 lb, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, gallbladder disorder, headache, metrorrhagia. ESTRACE dosage: unknown. During the same period patient was treated with ZESTRIL, PROGESTERONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Apr 05, 2006. Female patient, 67 years of age, weighting 240.3 lb, was diagnosed with hypertension and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: fatigue. ESTRACE dosage: unknown. During the same period patient was treated with MAXZIDE, CLONIDINE, PAMELOR, TOPROL. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2006. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with hot flush and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: hot flush. ESTRACE dosage: unknown. During the same period patient was treated with FLAXSEED. Patient recovered.
Health Professional from UNITED STATES reported ESTRACE problem on Apr 25, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: dry mouth, lethargy, performance status decreased, thinking abnormal. ESTRACE dosage: FORM = 1-2 MG A DAY. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2006. Female patient, 39 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: weight increased. ESTRACE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 12, 2006. Female patient, 60 years of age, weighting 127.9 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, THYROID. Patient was hospitalized. Patient recovered.
ESTRACE problem was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, 57 years of age, weighting 89.90 lb, was diagnosed with breast cancer and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, breast pain, herpes zoster, infection, white blood cell count increased. ESTRACE dosage: 10 MG TID PO. During the same period patient was treated with ACETAMINOPHEN, NEXIUM, NEURONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Jan 23, 2006. Female patient, 68 years of age, weighting 105.8 lb, was diagnosed with menopause and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRATAB, PREMARIN, PROVERA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2005. Female patient, 69 years of age, weighting 138.9 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, skin discolouration, skin haemorrhage, skin nodule. ESTRACE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 63 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, ORTHO, PREMPRO. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 46 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 68 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 69 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMPRO, PREMARIN, PROVERA, MEDROXYPROGESTERONE, CYCRIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 55 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMPRO, PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 62 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, FEMHRT, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 62 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer metastatic. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, PREMPRO. Patient died on 02/16/2006.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 61 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN. Patient died on 04/30/2005.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, ESTRADIOL, PROMETRIUM, MEDROXYPROGESTERONE. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Female patient, 52 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, ESTRATEST, VAGIFEM. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 07, 2006. Female patient, 55 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMPRO, PREMARIN, MEDROXYPROGESTERONE, FEMHRT, PROVERA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2006. Female patient, 70 years of age, weighting 191.8 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, breast cancer female. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, CYCRIN, MEDROXYPROGESTERONE ACETATE, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Apr 06, 2006. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with osteoporosis and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, AYGESTIN, EVISTA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PREMPRO, ESTRATEST, CENESTIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 28, 2006. Female patient, 74 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROMETRIUM. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 53 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, PREMARIN, ESTRATEST, CLIMARA, PROGESTERONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 28, 2006. Female patient, 50 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRACE CREAM, PREMARIN, PREMPRO, ESTRATEST, CENESTIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Sept 05, 2006. Female patient, 64 years of age, weighting 134.9 lb, was diagnosed with vulvovaginal dryness and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: altered visual depth perception, headache, optic neuritis, vaginal infection, vision blurred. ESTRACE dosage: 1 MG TWICE A WEEK, VAGINAL. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PREMPRO, ESTRATEST, CENESTIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Apr 06, 2006. Female patient, 58 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, PREMPRO. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2006. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with osteoporosis and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, AYGESTIN, EVISTA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Apr 06, 2006. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with osteoporosis and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, AYGESTIN, EVISTA, SYNTHROID, ATENOLOL, TIMOPTIC. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2006. Female patient, 58 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 25, 2007. Female patient, 48 years of age, was diagnosed with menopausal symptoms, depression and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer stage ii. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, ESTRATEST, ESTRADERM, ZOLOFT. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2007. Female patient, 57 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMPRO, MEDROXYPROGESTERONE ACETATE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 09, 2007. Female patient, 56 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, AYGESTIN, PROVERA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2007. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMPHASE, PREMARIN, PROVERA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 25, 2006. Female patient, 59 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: fungal infection. ESTRACE dosage: unknown. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Female patient, 65 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Dec 14, 2006. Female patient, 51 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, MEDROXYPROGESTERONE, CYCRIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2007. Female patient, 57 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PROMETRIUM, ESTRADIOL, MEDROXYPROGESTERONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Jan 03, 2007. Female patient, 61 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA. Patient died on 04/30/2005.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 53 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. ESTRACE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 07, 2007. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, carcinoid syndrome, diarrhoea, headache, hyperhidrosis, hypoaesthesia, palpitations, paraesthesia. ESTRACE dosage: 2 MG, QHS, ORAL. During the same period patient was treated with LEVOTHROID. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient, 67 years of age, weighting 115.0 lb, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: biopsy breast, breast cancer in situ, epistaxis, lymphoedema, massage, mastectomy, nasal polyps, oestrogen receptor assay positive, osteoporosis. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, ESTRADERM, ESTRATEST, PROVENTIL, BECLOVENT, VANCENASE. Patient recovered.
Health Professional from UNITED STATES reported ESTRACE problem on Aug 29, 2007. Female patient, 53 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, depression, somatisation disorder. ESTRACE dosage: unknown. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA, ESTROGEN, MEDROXYPROGESTERONE ACETATE, PRAMOSONE, ALPRAZOLAM, DONNATAL. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 69 years of age, was diagnosed with atrophic vulvovaginitis, pain and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, stomatitis. ESTRACE dosage: unknown. During the same period patient was treated with COUMADIN, ASPIRIN, AMANTADINE, LIPITOR, HYDROCHLOROTHIAZIDE, PREVACID. Patient recovered.